首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Developmentally regulated interconversions between end product-inhibitable and noninhibitable forms of a first pathway-specific enzyme activity can be mimicked in vitro by protein dephosphorylation-phosphorylation reactions.
【2h】

Developmentally regulated interconversions between end product-inhibitable and noninhibitable forms of a first pathway-specific enzyme activity can be mimicked in vitro by protein dephosphorylation-phosphorylation reactions.

机译:终产物抑制形式和非抑制形式的第一途径特异性酶活性之间的发育调控互变可以在体外通过蛋白质去磷酸化-磷酸化反应来模拟。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During the life cycle of Blastocladiella emersonii, dramatic shifts occur in the sensitivity of the first hexosamine biosynthetic pathway-specific enzyme [amidotransferase; 2-amino-2-deoxy-D-glucose-6-phosphate ketol-isomerase (amino-transferring), EC 5.3.1.19] to end product inhibition. These shifts are developmentally correlated with changes in the utilization of the end product (uridine-5'-diphospho-N-acetylglucosamine) for chitin synthesis [Selitrennikoff, C. P., Dalley, N. E. & Sonneborn, D. R. (1980) Proc. Natl. Acad. Sci. USA 77, 5998-6002]. Alterations in amidotransferase sensitivity to end product inhibition can be mimicked by in vitro protein dephosphorylation-phosphorylation reactions, as follows: (i) Zoospore end product-inhibitable amidotransferase activity can be converted to a noninhibitable form by an endogenous (zoospore) protein phosphatase (phosphoprotein phosphohydrolase EC 3.1.3.16) reaction; this noninhibitable form can be converted back to an inhibitable form either by an endogenous cAMP-independent protein kinase (ATP:protein phosphotransferase, EC 2.7.1.37) reaction or with an added cAMP-dependent protein kinase. (ii) Noninhibitable amidotransferase activity from growing cells can also be converted to the inhibitable form with added protein kinase.
机译:在艾美氏杆菌的生命周期中,第一种己糖胺生物合成途径特异性酶[amidotransferase; [2-氨基-2-脱氧-D-葡萄糖-6-磷酸酮醇异构酶(氨基转移),EC 5.3.1.19]以抑制终产物。这些变化与几丁质合成中终产物(尿苷-5'-二磷酸-N-乙酰基葡糖胺)利用的变化在发展上相关[Selitrennikoff,C.P.,Dalley,N.E。&Sonneborn,D.R。(1980)Proc.Natl.Acad.Sci.USA,87:3587-8877]。 Natl。学院科学USA 77,5998-6002]。酰胺基转移酶对终产物抑制敏感性的改变可以通过体外蛋白质去磷酸化-磷酸化反应来模拟,如下:(i)游动孢子终产物抑制性酰胺基转移酶的活性可以通过内源性(孢子)蛋白质磷酸酶(磷酸蛋白)转化为不可抑制的形式。磷酸水解酶EC 3.1.3.16)反应;这种不可抑制的形式可以通过内源性cAMP依赖性蛋白激酶(ATP:蛋白磷酸转移酶,EC 2.7.1.37)反应或添加的cAMP依赖性蛋白激酶转换回可抑制形式。 (ii)来自生长细胞的不可抑制的酰胺基转移酶活性也可以通过添加蛋白激酶转化为可抑制形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号